PDLIM4, an actin-binding protein containing PDZ and LIM domains, has been implicated as a tumor suppressor in prostate cancer and ovarian cancer due to its hypermethylation or downregulation feature [28]. This evidence concerns the gene PDLIM4 and prostate carcinoma.